Actively Recruiting
Project CONTINUITY: Promoting Evidence-Based Cancer Screening Among Underserved Women
Led by University of Florida · Updated on 2025-07-11
800
Participants Needed
1
Research Sites
30 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to improve adherence to cervical cancer screening among women living in high Social Vulnerability Index neighborhoods. It focuses on women aged 25 to 65 who have not had cervical cancer or a hysterectomy and who are due for screening. The project promotes personalized screening choices and addresses barriers like transportation through mobile outreach clinics to support underserved women in completing recommended screening and follow-up care. Participants can choose between two screening methods: the standard in-clinic Pap/HPV co-testing or HPV self-sampling completed outside a clinical setting. Women opting for self-testing will return their samples via mail or directly to community health workers. The study also involves surveys about cancer history and cervical cancer knowledge, along with follow-up support through calls and text messages from community navigators. During the study, participants will be monitored for adherence to the recommended steps in cervical cancer screening over six months. Researchers will collect information through surveys, follow-up messages, and tracking of screening completion. The study will evaluate how well women follow the screening continuum, with ongoing support and strategies to address social factors affecting care. Participation lasts at least six months with continued monitoring of screening adherence.
CONDITIONS
Brief Title
Project CONTINUITY: Promoting Evidence-Based Cancer Screening Among Underserved Women
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 25 to 65 years
- Assigned female sex at birth
- No previous history of cervical cancer
- No previous history of a hysterectomy
- Not currently pregnant
- Not currently menstruating
- No use of vaginal products like oil-based lubricants, antifungals, or douches in the prior 2 days (water-based lubricants, condoms, and vaginal contraceptives allowed)
- No childbirth in the prior 12 weeks
- No cervical cancer screening in past 4 years or past due per provider recommendation
- Self-report use of Mobile Outreach Clinic in the past, no current usual source of care, or usual care provider does not offer cervical cancer screening
- Reside in areas served by the Mobile Outreach Clinic
- Have access to a mobile phone or valid email address
You will not qualify if you...
- Currently menstruating
- Use of vaginal products such as oil-based lubricants, antifungal medications, or douches within 2 days before screening
- Gave birth within the past 12 weeks
- If excluded for menstruation, recent vaginal product use, or recent childbirth, participants may be re-contacted up to 20 weeks later for possible future eligibility
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or remote) for eligibility assessment
Duration - Up to 1 month
Participants choose between completing an HPV self-test in a non-clinical setting or receiving a standard in-clinic Pap test for cervical cancer screening.
1 visit if choosing in-clinic Pap test; self-testing and mail return if choosing HPV self-test
Duration - Concurrent with screening choice and testing period
Participants respond to questions about their cancer history and knowledge of cervical cancer prevention and screening.
1 survey session (in-person or remote)
Duration - 6 months
Participants are observed for adherence to cervical cancer screening follow-up steps over time.
Follow-up contacts via telephone calls and text messages from community clinical navigators and community health workers
Trial Site Locations
Total: 1 location
1
University of Florida
Gainesville, Florida, United States, 32610
Actively Recruiting
Research Team
J
Jamie Barrow, MHA, CCRP
J
Jennifer N Woodard, MPH, CCRP
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here